Work

Abstract PS1-05-15: Trends in the Utilization of Prophylactic Anti-Emetic Therapy among Patients Initiating trastuzumab deruxtecan for Metastatic Breast Cancer in the United States

Year: 2026

Type: conference-abstract

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps1-05-15

Authors: C. H. Shah, C. Nordon, E. Langford, X. Zhao, B. Adeyemi, E. John, A. M. Near, H. Moore

Institutions: AstraZeneca (United Kingdom), IQVIA (United States), Duke Cancer Institute

Language: English

Topic: Nausea and vomiting management

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7130682127

Cites:

Cited by:

Related to: